• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价支链氨基酸和锌补充剂联合治疗对肝硬化患者氮代谢的影响。

Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis.

机构信息

Department of Internal Medicine, Osaka Koseinenkin Hospital, Osaka, Japan.

出版信息

Hepatol Res. 2007 Aug;37(8):615-9. doi: 10.1111/j.1872-034X.2007.00095.x. Epub 2007 May 22.

DOI:10.1111/j.1872-034X.2007.00095.x
PMID:17517070
Abstract

AIM

Disorders of protein metabolism in liver cirrhosis can affect prognosis or cause complications. Treatment with branched-chain amino acid (BCAA) and zinc supplements has been shown to be effective against abnormal nitrogen metabolism in liver cirrhosis. There are, however, few studies on the effects of combining these supplements. In this study, the effect of combining BCAA and zinc treatment in cirrhosis was investigated.

METHODS

Forty patients with liver cirrhosis who had blood albumin levels of 3.5 g/dL or less and blood zinc levels of 70 mug/dL or less were randomized to receive either BCAA alone or a combination of BCAA and zinc supplements. Blood albumin, the Fischer ratio, and ammonia levels were compared over 5-6 months of treatment.

RESULTS

In the combination group, the post/pre treatment change ratio in blood ammonia levels decreased significantly (0.87 +/- 0.26 vs. 1.22 +/- 0.38, P = 0.0033), and the change ratio in the Fischer ratio increased significantly (1.22 +/- 0.29 vs. 1.08 +/- 0.16, P = 0.0165) in comparison with the BCAA monotherapy group. The change ratio in blood albumin levels showed no significant difference between the groups (1.01 +/- 0.07 vs. 1.03 +/- 0.08, P = 0.4646).

CONCLUSIONS

More improvement in disorders of nitrogen metabolism in liver cirrhosis occurred after administration of BCAA with zinc than after BCAA alone over 5-6 months of treatment. Further investigation is necessary to determine mechanisms of the action and longer-term clinical efficacy.

摘要

目的

肝硬化患者的蛋白质代谢紊乱可影响预后或导致并发症。支链氨基酸(BCAA)和锌补充剂的治疗已被证明可有效治疗肝硬化的氮代谢异常。然而,关于联合使用这些补充剂的研究很少。本研究旨在探讨联合使用 BCAA 和锌治疗肝硬化的效果。

方法

将 40 名血白蛋白水平<3.5g/dL 且血锌水平<70μg/dL 的肝硬化患者随机分为单独接受 BCAA 或 BCAA 和锌补充剂联合治疗。比较治疗 5-6 个月后血白蛋白、Fischer 比值和血氨水平的变化。

结果

联合治疗组血氨水平的治疗前后变化比显著降低(0.87±0.26 对 1.22±0.38,P=0.0033),Fischer 比值的变化比显著升高(1.22±0.29 对 1.08±0.16,P=0.0165),与 BCAA 单药治疗组相比。两组间血白蛋白水平的变化比无显著差异(1.01±0.07 对 1.03±0.08,P=0.4646)。

结论

与单独使用 BCAA 相比,在 5-6 个月的治疗期间,联合使用 BCAA 和锌可更有效地改善肝硬化患者的氮代谢紊乱。需要进一步研究以确定其作用机制和长期临床疗效。

相似文献

1
Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis.评价支链氨基酸和锌补充剂联合治疗对肝硬化患者氮代谢的影响。
Hepatol Res. 2007 Aug;37(8):615-9. doi: 10.1111/j.1872-034X.2007.00095.x. Epub 2007 May 22.
2
Late evening snacks with branched-chain amino acids improve the Fischer ratio with patients liver cirrhosis at fasting in the next morning.晚间食用含支链氨基酸的零食可提高肝硬化患者次日清晨空腹时的费希尔比率。
Clin Nutr ESPEN. 2019 Apr;30:138-144. doi: 10.1016/j.clnesp.2019.01.003. Epub 2019 Jan 24.
3
Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis.长期口服支链氨基酸颗粒对肝硬化预后的影响。
Gastroenterol Jpn. 1989 Dec;24(6):692-8. doi: 10.1007/BF02774169.
4
Effect of oral supplementation with branched-chain amino acid granules in the early stage of cirrhosis.口服补充支链氨基酸颗粒剂在肝硬化早期的作用
Hepatol Res. 2004 Dec;30S:36-41. doi: 10.1016/j.hepres.2004.08.009. Epub 2004 Nov 10.
5
Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis.支链氨基酸颗粒对失代偿期和代偿期肝硬化疗效的比较。
Hepatogastroenterology. 2009 Nov-Dec;56(96):1719-23.
6
Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration.夜间给予支链氨基酸可改善肝硬化患者的蛋白质代谢:与日间给予的比较。
JPEN J Parenter Enteral Nutr. 2003 Sep-Oct;27(5):315-22. doi: 10.1177/0148607103027005315.
7
Zinc and protein metabolism in chronic liver diseases.慢性肝病中的锌与蛋白质代谢
Nutr Res. 2020 Feb;74:1-9. doi: 10.1016/j.nutres.2019.11.009. Epub 2019 Nov 27.
8
Branched chain amino acid therapy in liver disease.肝病中的支链氨基酸疗法。
J Am Coll Nutr. 1985;4(6):639-50. doi: 10.1080/07315724.1985.10720106.
9
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.支链氨基酸作为肝硬化中的蛋白质和能量来源。
Biochem Biophys Res Commun. 2004 Jan 9;313(2):405-9. doi: 10.1016/j.bbrc.2003.07.016.
10
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.口服支链氨基酸颗粒对肝硬化患者无事件生存期的影响。
Clin Gastroenterol Hepatol. 2005 Jul;3(7):705-13. doi: 10.1016/s1542-3565(05)00017-0.

引用本文的文献

1
Hepatic encephalopathy in cirrhosis: therapies and developments.肝硬化中的肝性脑病:治疗方法与进展
Metab Brain Dis. 2025 May 7;40(5):198. doi: 10.1007/s11011-025-01598-7.
2
Hypozincemia Is Associated With Increased Tyrosine Levels, Low Handgrip Strength, Increased Incidence of HCC, and Liver Disease Progression-A Cross-Sectional Study.低锌血症与酪氨酸水平升高、握力降低、肝癌发病率增加及肝病进展相关——一项横断面研究
JGH Open. 2025 Mar 18;9(3):e70124. doi: 10.1002/jgh3.70124. eCollection 2025 Mar.
3
Antiviral activity of zinc against hepatitis viruses: current status and future prospects.
锌对肝炎病毒的抗病毒活性:现状与未来前景
Front Microbiol. 2023 Oct 16;14:1218654. doi: 10.3389/fmicb.2023.1218654. eCollection 2023.
4
Biological Role of Zinc in Liver Cirrhosis: An Updated Review.锌在肝硬化中的生物学作用:最新综述
Biomedicines. 2023 Apr 4;11(4):1094. doi: 10.3390/biomedicines11041094.
5
Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial).锌补充剂治疗轻微型肝性脑病的疗效:一项前瞻性、随机对照研究(Zinc-MHE 试验)。
Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2879-2887. doi: 10.31557/APJCP.2021.22.9.2879.
6
The role of skeletal muscle in the pathogenesis of altered concentrations of branched-chain amino acids (valine, leucine, and isoleucine) in liver cirrhosis, diabetes, and other diseases.骨骼肌在肝硬化、糖尿病和其他疾病中支链氨基酸(缬氨酸、亮氨酸和异亮氨酸)浓度改变的发病机制中的作用。
Physiol Res. 2021 Jul 12;70(3):293-305. doi: 10.33549/physiolres.934648. Epub 2021 May 12.
7
Effect of zinc treatment on clinical outcomes in patients with liver cirrhosis: A systematic review and meta-analysis.锌治疗对肝硬化患者临床结局的影响:一项系统评价和荟萃分析。
World J Hepatol. 2020 Jul 27;12(7):389-398. doi: 10.4254/wjh.v12.i7.389.
8
Protective effects of synbiotic soymilk fortified with whey protein concentrate and zinc sulfate against bile duct ligated-induced hepatic encephalopathy.添加浓缩乳清蛋白和硫酸锌的合生元豆浆对胆管结扎诱导的肝性脑病的保护作用。
Gastroenterol Hepatol Bed Bench. 2020 Winter;13(1):64-76.
9
Nutritional Challenges in Patients with Advanced Liver Cirrhosis.晚期肝硬化患者的营养挑战
J Clin Med. 2019 Nov 9;8(11):1926. doi: 10.3390/jcm8111926.
10
Effects of Zinc Acetate on Serum Zinc Concentrations in Chronic Liver Diseases: a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial and a Dose Adjustment Trial.醋酸锌对慢性肝病患者血清锌浓度的影响:一项多中心、双盲、随机、安慰剂对照试验和剂量调整试验。
Biol Trace Elem Res. 2020 May;195(1):71-81. doi: 10.1007/s12011-019-01851-y. Epub 2019 Aug 7.